F&V Capital Management LLC lessened its stake in Allstate Corp (NYSE:ALL) by 1.6% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 71,530 shares of the insurance provider’s stock after selling 1,150 shares during the quarter. Allstate makes up about 3.9% of F&V Capital Management LLC’s holdings, making the stock its 7th largest position. F&V Capital Management LLC’s holdings in Allstate were worth $7,490,000 as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds also recently bought and sold shares of the company. Canada Pension Plan Investment Board increased its position in Allstate by 3.1% in the third quarter. Canada Pension Plan Investment Board now owns 491,833 shares of the insurance provider’s stock worth $45,204,000 after buying an additional 14,700 shares during the last quarter. Aperio Group LLC grew its position in shares of Allstate by 16.4% in the third quarter. Aperio Group LLC now owns 410,026 shares of the insurance provider’s stock valued at $37,685,000 after purchasing an additional 57,713 shares in the last quarter. Caisse DE Depot ET Placement DU Quebec grew its position in shares of Allstate by 2.0% in the third quarter. Caisse DE Depot ET Placement DU Quebec now owns 85,160 shares of the insurance provider’s stock valued at $7,860,000 after purchasing an additional 1,700 shares in the last quarter. Toronto Dominion Bank grew its position in shares of Allstate by 11.1% in the third quarter. Toronto Dominion Bank now owns 137,390 shares of the insurance provider’s stock valued at $12,627,000 after purchasing an additional 13,713 shares in the last quarter. Finally, BT Investment Management Ltd grew its position in shares of Allstate by 2.5% in the third quarter. BT Investment Management Ltd now owns 215,126 shares of the insurance provider’s stock valued at $19,800,000 after purchasing an additional 5,268 shares in the last quarter. Institutional investors own 76.56% of the company’s stock.
Allstate Corp (ALL) opened at $102.13 on Wednesday. The firm has a market capitalization of $36,639.72, a price-to-earnings ratio of 14.18, a PEG ratio of 1.54 and a beta of 1.12. The company has a debt-to-equity ratio of 0.31, a quick ratio of 0.26 and a current ratio of 0.26. Allstate Corp has a twelve month low of $73.39 and a twelve month high of $105.36.
Allstate (NYSE:ALL) last posted its quarterly earnings data on Wednesday, November 1st. The insurance provider reported $1.60 EPS for the quarter, missing the consensus estimate of $1.61 by ($0.01). The company had revenue of $8.12 billion during the quarter, compared to analysts’ expectations of $8.07 billion. Allstate had a return on equity of 13.11% and a net margin of 7.32%. The company’s revenue for the quarter was up 3.2% on a year-over-year basis. During the same quarter last year, the company earned $1.26 earnings per share. sell-side analysts predict that Allstate Corp will post 6.15 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, January 2nd. Shareholders of record on Thursday, November 30th were issued a dividend of $0.37 per share. This represents a $1.48 annualized dividend and a dividend yield of 1.45%. The ex-dividend date was Wednesday, November 29th. Allstate’s dividend payout ratio (DPR) is presently 20.56%.
In related news, Chairman Thomas J. Wilson sold 195,000 shares of Allstate stock in a transaction that occurred on Thursday, November 9th. The shares were sold at an average price of $99.13, for a total transaction of $19,330,350.00. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Suren Gupta sold 103,242 shares of Allstate stock in a transaction that occurred on Friday, November 10th. The shares were sold at an average price of $98.68, for a total transaction of $10,187,920.56. The disclosure for this sale can be found here. Insiders have sold a total of 432,242 shares of company stock valued at $42,827,931 in the last three months. Insiders own 1.50% of the company’s stock.
ALL has been the subject of several research analyst reports. UBS Group dropped their price objective on Allstate from $94.00 to $93.00 and set a “neutral” rating for the company in a research note on Tuesday, September 19th. Citigroup dropped their price target on Allstate from $107.00 to $106.00 and set a “buy” rating for the company in a research note on Monday, October 2nd. Zacks Investment Research lowered Allstate from a “hold” rating to a “sell” rating in a research note on Tuesday, October 10th. Wells Fargo & Co set a $105.00 price objective on Allstate and gave the stock a “buy” rating in a report on Thursday, October 19th. Finally, Credit Suisse Group boosted their price target on Allstate from $91.00 to $95.00 and gave the company a “neutral” rating in a report on Thursday, November 2nd. Two analysts have rated the stock with a sell rating, nine have issued a hold rating and four have issued a buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus price target of $96.43.
TRADEMARK VIOLATION NOTICE: “F&V Capital Management LLC Has $7.49 Million Holdings in Allstate Corp (ALL)” was posted by The Ledger Gazette and is owned by of The Ledger Gazette. If you are viewing this story on another site, it was copied illegally and republished in violation of US and international trademark & copyright law. The correct version of this story can be read at https://ledgergazette.com/2018/01/17/allstate-corp-all-shares-sold-by-fv-capital-management-llc.html.
The Allstate Corporation (Allstate) is a holding company for Allstate Insurance Company. The Company’s business is conducted principally through Allstate Insurance Company, Allstate Life Insurance Company and other subsidiaries. It is engaged in the property-liability insurance business and the life insurance, retirement and investment products business.
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.